Stay updated with breaking news from Boris Kovatchev. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A meta-analysis of trials examining use of the t:slim X2 insulin pump with Control-IQ technology, results of the study indicate use of the hybrid closed loop technology was associated with improvements in glycemic control, regardless of patient age, race, or previous CGM use.
An artificial pancreas developed at the University of Virginia Center for Diabetes Technology improves blood sugar control for people ages 2 to 72 with type 1 diabetes, according to a new combined analysis of three clinical trials.
A new combined analysis has determined that an artificial pancreas developed at UVA improves blood sugar for children and adults.
Tandem Diabetes Care, Inc. , a leading insulin delivery and diabetes technology company, today announced publication by Diabetes Technology & Therapeutics of a meta-analysis of three randomized... | April 17, 2023
This wearable device senses blood glucose and administers insulin accordingly.